2m 2m 2m 2m 2m 2m 2m
ENSYSCE BIO (ENSC)
NASDAQ
$0.52+$0.009 (+1.76%)
Price as of Oct 22, 2026 6:42 PM EDT- $10.1MMarket Cap
- -75.78%1-Year Change
- BiotechnologyIndustry
ENSYSCE BIO (ENSC)
$0.52+$0.009 (+1.76%)
ENSC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.51 | ||
Change | -$0.009 (-1.73%) | ||
Open | $0.52 | ||
High | $0.55 | ||
Low | $0.51 | ||
Previous Close | $0.52 | ||
Volume | 356,506 | ||
30-Day Average Volume | 537,913 | ||
1-Week Change | -14.53% | ||
1-Month Change | 19.11% | ||
1-Year Change | -75.78% | ||
3-Year Change | -97.27% | ||
5-Year Change | -99.99% | ||
Fundamentals | |||
Shares Outstanding | 19.5M | ||
Total Assets | $3.0M | ||
Market Cap | $10.1M | ||
Enterprise Value | $9.8M | ||
Period: QTR TTM FY | |||
Revenue | $1.2M | ||
Net Income | -$2.6M | ||
Free Cash Flow | -$2.0M | ||
EBIT | -$2.6M | ||
EBITDA | -$2.6M | ||
Net Working Capital | -$1.2M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 8 | ||
P/B | -13 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 12/06/2024 | ||
Earnings & Revenue